Full Name
Dr. Matthew Miller
Job Title
Executive Director, M.G. DeGroote Institute for Infectious Disease Research
Company / Affiliation
McMaster University
Speaker Bio
Dr. Miller is an Associate Professor, Associate Chair, and Assistant Dean in the Department of Biochemistry and Biomedical Sciences at McMaster University. He holds a Canada Research Chair in Viral Pandemics and is currently Secretary-Treasurer of the Canadian Society for Virology.
Dr. Miller completed his PhD in Microbiology & Immunology at the University of Western Ontario, where he studied the molecular virology and pathogenesis of DNA viruses. He went on to complete a CIHR-funded postdoctoral fellowship with Dr. Peter Palese at the Icahn School of Medicine at Mount Sinai in New York, NY where his research focus shifted to the study of pandemic influenza and the design of “universal” influenza virus vaccines. Dr. Miller was recruited to McMaster University in 2014 has been focused on issues related to pandemic preparedness – especially vaccinology, and the impact of viral infections on the onset and progression of neurodegenerative diseases (e.g., ALS). He has been awarded a CIHR New Investigator Award, the CIHR Bhagirath Singh Early Career Award in Infection and Immunity, and an Early Researcher Award from the Government of Ontario.
Since early 2020, Dr. Miller has been heavily engaged in COVID-19 research, including development of next-generation COVID-19 vaccines, therapeutics, and diagnostics. He is a member of the National Advisory Committee on Immunization (NACI) COVID-19 Working Group, the Federal Variants-of-Concern Leadership Group, and the Federal Pandemic Science Coordination and Action Group.
Dr. Miller completed his PhD in Microbiology & Immunology at the University of Western Ontario, where he studied the molecular virology and pathogenesis of DNA viruses. He went on to complete a CIHR-funded postdoctoral fellowship with Dr. Peter Palese at the Icahn School of Medicine at Mount Sinai in New York, NY where his research focus shifted to the study of pandemic influenza and the design of “universal” influenza virus vaccines. Dr. Miller was recruited to McMaster University in 2014 has been focused on issues related to pandemic preparedness – especially vaccinology, and the impact of viral infections on the onset and progression of neurodegenerative diseases (e.g., ALS). He has been awarded a CIHR New Investigator Award, the CIHR Bhagirath Singh Early Career Award in Infection and Immunity, and an Early Researcher Award from the Government of Ontario.
Since early 2020, Dr. Miller has been heavily engaged in COVID-19 research, including development of next-generation COVID-19 vaccines, therapeutics, and diagnostics. He is a member of the National Advisory Committee on Immunization (NACI) COVID-19 Working Group, the Federal Variants-of-Concern Leadership Group, and the Federal Pandemic Science Coordination and Action Group.
Speaking At